Picture of Aker Biomarine ASA logo

AKBM Aker Biomarine ASA News Story

0.000.00%
no flag iconLast trade - 00:00
Consumer DefensivesSpeculativeMid CapMomentum Trap

Brief: Aker Biomarine Q2 Adjusted EBITDA USD 21 Million, Up 11% y-o-y

July 14 (Reuters) - Aker Biomarine ASA  AKBM.OL :
    * REVENUES OF USD 73 MILLION AND ADJUSTED EBITDA OF USD 21
MILLION
FOR Q2 2022.
    * Q2 REVENUES OF USD 73 MILLION, ON PAR WITH SAME QUARTER
LAST
YEAR
    * Q2 ADJUSTED EBITDA OF USD 21 MILLION, UP 11% FROM SAME
QUARTER
LAST YEAR
    * ECONREITERATES ITS TARGETS FOR 2022

Source text for Eikon:  ID:nObiLgrBja 
Further company coverage:  AKBM.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Aker Biomarine ASA

See all news